UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325

Clinical psychopathological features of nonpsychotic mental disorders in patients with rheumatoid arthritis dependent on the disease duration

Authors

Type of Article

In the Section

Index UDK:

Abstract

The clinical-psychopathological features of nonpsychotic mental disorders (NMD) in patients with rheumatoid arthritis (RA) depending on the duration of the disease are described in the article. On the basis of a comprehensive clinical psychopathological study data were obtained on the structure of NMD in RA: in the main group with a total duration of rheumatoid arthritis up to 5 years (MG I) in comparison with the main group with duration of rheumatoid arthritis from 5 to 10 years (MG II), were predominantly disorders of adaptation on 11.9 %: 27.3 % in MG I and 15.4 % in MG IІ (p < 0.05); somatoform disorder was more often diagnosed with an advantage of 11.3 % with 23.6 % in MG I and 12.3 % in MG II (p < 0.04); anxious-phobic disorder was dominated by 15.4 %: 20.0 % in MG I and 4.6 % in MG II (p < 0.006), and in the MG II, compared with the MG I, the mixed anxiety-depressive disorder was more often diagnosed with an advantage of 34.2 %, namely 61.5 % and 27.3 % (p < 0.0001). On the measure of the development of RA, the general indexes of the level of depression increased from 9,16 points to 10.84 point(p < 0.05) and general indexes of the level of anxiety — from 11,10 points to 13,12 point (p < 0.05). The system of diagnostic of NMD in patients with RA has been scientifi cally substantiated, developed and implemented, as a result of the conducted clinical and psychopathological research.

Pages

References

  1. Andryushchenko A. V., Romanov D. V. Clinical and epidemiological aspects of borderline mental and psychosomatic disorders in general medicine (literature review) // Mental disorders in general medicine. 2010. No. 02. Pp. 23–42.
  2. Symptoms of depression and anxiety predict treatment response and long-term physical health outcomes in rheumatoid arthritis: secondary analysis of  a  randomized controlled trial  / Matcham F., Norton S., Scott D. L. [et al.] // Rheumatology (Oxford). 2016. 55(2). Р. 268—278.
  3. The correlations of socioeconomic status, disease activity, quality of  life, and depression/anxiety in  Chinese patients with rheumatoid arthritis / Zhang L., Xia Y., Zhang Q. [et al.] // Psychol Health Med. 2017. 22(1) Р. 28—36.
  4. Guo J., Li L., Yang J. Investigation and analysis of anxiety and depression of patients with rheumatoid arthritis // Rheum Arthritis. 2012. 1 (3). Р. 28—9.
  5. Li Liu, Neili Xu, Lie Wang. Moderating role of self-efficacy on  the associations of  social support with depressive and anxiety symptoms in  Chinese patients with rheumatoid arthritis  // Neuropsychiatric disease and treatment. 2017. 13. Р. 2141—2150.
  6. Spirina I. D., Timofeev R. M., Shornikov A. V. The role of stress response and "immature" mental defense mechanisms in the formation of neurotic, stress-related, and somatoform disorders // Ukrainian Journal of Psychoneurology. 2018. Vol. 26, issue 1 (94). Pp. 92–94.
  7. Maruta N. O., Fedchenko V. Yu., Linska K. I. Genetic predisposition to depressive disorders // Ibid. 2017. Vol. 25, issue 3 (92). Pp. 39–43.
  8. Van den Hoek J., Boshuizen H. C., Roorda L. D. Association of somatic comorbidities and comorbid depression with mortality in patients with rheumatoid arthritis: a 14-year prospective cohort study // Arthritis Care Res (Hoboken). 2016. 68 (8) Р. 1055—60.
  9. Savka S. D. Evaluation of depression and its correlation with anxiety, quality of life index and duration of disease in  patients with rheumatoid arthritis // “The Top Actual Researches in Modern Science” : Proceedings of the international scientific and practical conference (Ajman, UAE, 31 July 2017, UAE)  / Ramachandran  N. (Eds.). 2017. № 8 (24). Р. 50—3.